Evidence map›Paper›PMID 39190595›Full record

Observational studyJournal of the American Heart Association2024

Cerebrovascular Events in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Pooled Patient-Level Study.

Astrid C van Nieuwkerk, Hugo M Aarts, Kimberley I Hemelrijk, Cristobal Urbano Carrillo, Didier Tchétché, Fabio S de Brito, Marco Barbanti, Ran Kornowski, Azeem Latib, Augusto D'Onofrio and 14 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03588247 (Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves.), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03588247 completednot on this map

Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves.

Typeobservational_patient_registrySponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Ran2017 to 2023Enrolled12,000ConditionsAortic Valve StenosisArmstranscatheter aortic valve implantation
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Observational
  2. Pre-Existing and New-Onset Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. What Are SAVR Indications in the TAVI Era?Journal of clinical medicine · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Journal of the American Heart Association · 2024
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Astrid C van NieuwkerkDepartment of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.ORCID 0000-0001-7051-2296
Hugo M AartsDepartment of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.ORCID 0000-0003-0852-8275
Kimberley I HemelrijkDepartment of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.ORCID 0000-0002-7803-189X
Cristobal Urbano CarrilloHospital Regional Universitario de Málaga Malaga Spain.ORCID 0000-0002-9504-8861
Didier TchétchéClinique Pasteur Toulouse France.
Fabio S de BritoHeart Institute, University of São Paulo Medical School São Paulo Brazil.
Marco BarbantiUniversità degli Studi di Enna "Kore" Enna Italy.ORCID 0000-0002-4903-5437
Ran KornowskiCardiology Department Rabin Medical Center Petach Tikva Israel.ORCID 0000-0002-7708-8253
Azeem LatibDepartment of Cardiology Montefiore Medical Center New York NY USA.ORCID 0000-0001-9035-343X
Augusto D'OnofrioDivision of Cardiac Surgery University of Padova Padova Italy.ORCID 0000-0002-9835-9091
Flavio RibichiniDivision of Cardiology, Department of Medicine University of Verona Verona Italy.ORCID 0000-0002-6662-0304
Sergio García-BlasClínico Universitario de Valencia Valencia Spain.ORCID 0000-0002-1998-3735
Nicolas DumonteilClinique Pasteur Toulouse France.
Alexandre AbizaidHeart Institute, University of São Paulo Medical School São Paulo Brazil.ORCID 0000-0001-8689-9990
Samantha SartoriThe Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY USA.ORCID 0000-0003-0618-9409
Paola D'ErrigoNational Centre for Global Health-Istituto Superiore di Sanità Rome Italy.ORCID 0000-0002-3174-4278
Giuseppe TarantiniDivision of Cardiac Surgery University of Padova Padova Italy.ORCID 0000-0002-5055-2917
Mattia LunardiDivision of Cardiology, Department of Medicine University of Verona Verona Italy.ORCID 0000-0001-8344-6048
Katia OrvinCardiology Department Rabin Medical Center Petach Tikva Israel.ORCID 0000-0003-2523-6469
Matteo PagnesiDepartment of Medical and Surgical Specialties, Institute of Cardiology, Radiological Sciences and Public Health, ASST Spedali Civili University of Brescia Brescia Italy.ORCID 0000-0002-9298-7871
Felipe NavarroFundacion Jimenez Diaz Ute Madrid Spain.ORCID 0009-0009-8441-0405
George DangasThe Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY USA.ORCID 0000-0001-7502-8049
Roxana MehranThe Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY USA.ORCID 0000-0002-5546-262X
Ronak DelewiDepartment of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.ORCID 0000-0001-6070-9423

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCerebrovascular events remain one of the most devastating complications of transcatheter aortic valve implantation (TAVI). Data from real-world contemporary cohorts on longitudinal trends and outcomes remain limited. The aim of this study was to assess incidence, temporal trends, predictors, and outcomes of cerebrovascular events following transfemoral TAVI. METHODS AND

resultsThe CENTER2 (Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Implantation With Balloon-Expandable Valves Versus Self-Expandable Valves 2) study includes patients undergoing TAVI between 2007 and 2022. The database contains pooled patient-level data from 10 clinical studies. A total of 24 305 patients underwent transfemoral TAVI (mean age 81.5±6.7 years, 56% women, median Society of Thoracic Surgeon Predicted Risk of Mortality 4.9% [3.1%-8.5%]). Of these patients, 2.2% (n=534) experienced stroke in the first 30 days after TAVI, and 40 (0.4%) had a transient ischemic attack. Stroke rates remained stable during the treatment period (2007-2010: 2.1%, 2011-2014: 2.5%, 2015-2018: 2.1%, 2019-2022: 2.1%;

conclusionsIn 24 305 patients who underwent transfemoral TAVI, 30-day cerebrovascular event incidence remained ≈ 2.2% between 2007 and 2022. Thirty-day stroke rates were similar throughout Society of Thoracic Surgeon Predicted Risk of Mortality risk categories. Mortality rates after stroke remain high. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03588247.

Indexed as

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overAortic ValveFemaleFemoral ArteryHumansIncidenceIschemic Attack, TransientMalePostoperative ComplicationsRisk AssessmentRisk FactorsStrokeTime Factorsaortic valve stenosismortalitystroketranscatheter aortic valve replacement

Identifiers

PMID39190595
PMCPMC11646506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.